Shanghai, China

Yinglu Jiao

This inventor holds 1 USPTO granted patent. Top assignees: Shanghai Aobo Pharmtech, Inc., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd.. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yinglu Jiao: Innovator in Pharmaceutical Chemistry

Introduction

Yinglu Jiao is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new drug formulations. His work has led to advancements that are beneficial for industrial production.

Latest Patents

Yinglu Jiao holds a patent for the "Crystal form of brexpiprazole and preparation method therefor." This patent discloses a crystal form of brexpiprazole, characterized by an X-ray powder diffraction pattern detected with Cu—Kα radiation. The crystal form exhibits characteristic peaks at specific positions, indicating its unique properties. The crystal form I of brexpiprazole is noted for its high purity, good stability, and reproducibility, making it suitable for industrial production. He has 1 patent to his name.

Career Highlights

Throughout his career, Yinglu Jiao has worked with prominent companies in the pharmaceutical industry. He has been associated with Shanghai Aobo Pharmtech, Inc., Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. His expertise in drug formulation has been instrumental in the development of effective pharmaceutical products.

Collaborations

Yinglu Jiao has collaborated with several professionals in his field, including Handa Li and Yang Liu. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yinglu Jiao is a distinguished inventor whose work in pharmaceutical chemistry has led to significant innovations. His contributions, particularly in the formulation of brexpiprazole, highlight his impact on the industry. His ongoing efforts continue to shape the future of pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…